DBD Earnings & Financial Statements
Diebold Nixdorf, Incorporated
$66.45
+$2.16(+3.36%)
54
Overall
80
Value
18
Tech
65
Quality
Market Cap
$2.21B
Volume
51.22K
52W Range
$54.48 - $92.09
Target Price
$98.33
DBD earnings and financial statements: Diebold Nixdorf, Incorporated's income statement, balance sheet and cash flow statement, annual and quarterly.
DBD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $3.75B | $1.63B | $3.46B | $3.91B |
| Cost of revenue | - | $2.83B | $1.28B | $2.70B | $2.86B |
| Operating income | - | $182.10M | $92.40M | -$211.70M | $137.10M |
| EBITDA | - | $339.30M | $133.00M | -$165.30M | $311.30M |
| Net income | - | -$16.50M | $13.40M | -$581.40M | -$78.80M |
| EPS (diluted) | $2.54 | $-0.44 | $0.47 | $-7.36 | $-1.01 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DBD | $66.45 | +3.4% | 51.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Diebold Nixdorf, Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW